z-logo
open-access-imgOpen Access
Dapagliflozin as Additional Treatment to Liraglutide and Insulin in Patients With Type 1 Diabetes
Author(s) -
Nitesh Kuhadiya,
Husam Ghanim,
Aditya Mehta,
Manisha Garg,
Salman Khan,
Jeanne Hejna,
Barrett Torre,
Antoine Makdissi,
Ajay Chaudhuri,
Manav Batra,
Paresh Dandona
Publication year - 2016
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2016-1451
Subject(s) - liraglutide , dapagliflozin , type 2 diabetes , medicine , insulin , diabetes mellitus , endocrinology
It is imperative that novel approaches to treatment of type 1 diabetes (T1D) are devised.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom